Music intervention rejuvenates certain regions of the older brain: study
By
Alicia Lasek
Apr 24, 2023
Listening to music and playing a musical instrument may help to avert brain aging in the areas related to these actions, researchers in Switzerland and Germany have found.
COVID vaccines lost some effectiveness in delta surge, ongoing CDC study finds
By
Alicia Lasek
Aug 25, 2021
The three federally sanctioned COVID vaccines have lost a “moderate” amount of effectiveness against SARS-CoV-19 ever since the delta gene variant became the predominant U.S. strain, the agency reports.
Long-term study links infections to 70 percent higher dementia risk
By
Alicia Lasek
Jan 10, 2023
A study with 32 years of followup has linked infections in hospitalized patients to future dementia onset. Urinary tract infections are among those with the strongest link.
HHS halts Eli Lilly’s single-drug COVID antibody treatment in U.S.; dual-drug alternative remains in...
By
Alicia Lasek
Mar 26, 2021
U.S. distribution of an infusion treatment using bamlanivimab only has been halted due to virus variant concerns, but an alternative antibody cocktail from the drugmaker can still be ordered, according...
Parkinson’s breakthrough: Researchers find way to halt disease progression
By
Alicia Lasek
Jun 07, 2019
Japanese researchers have successfully reduced Parkinson’s-like symptoms in mice. The breakthrough could unearth preventive treatments, they said.
Epilepsy raises risk of developing Alzheimer’s, and vice-versa
By
Alicia Lasek
May 29, 2023
People with a common type of epilepsy have nearly four times the relative odds of receiving an Alzheimer’s diagnosis, a new study finds.
FDA OKs third antibody COVID therapy; variants spur new pause on another
By
Alicia Lasek
Jun 01, 2021
A new COVID-19 treatment made by GlaxoSmithKline now is the third monoclonal antibody therapy federally authorized to help prevent severe disease outcomes in high-risk patients. But gene variants are interfering...
Gout guidance highlights treat-to-target drug therapy
By
Alicia Lasek
May 12, 2020
Experts strongly recommend moving away from a fixed-dose approach to urate lowering therapy in updated guidelines for 2020.
FDA to withdraw certain drug-related guidances with end of PHE
By
Alicia Lasek
Mar 14, 2023
The Food and Drug Administration has issued a notice detailing which COVID-19-related guidances will expire when the public health emergency ends as scheduled on May 11, and which guidances will remain...
High amyloid levels linked to early-stage Alzheimer’s
By
Alicia Lasek
Apr 06, 2020
Screening data from an Alzheimer’s drug trial suggests that higher brain amyloid levels exist well before clinical symptoms appear.